AbbVie reevaluating Shire acquisition

AbbVie Inc. (NYSE: ABBV) was reevaluating it plan to purchase Shire (Nasdaq: SHPG). Shares of AbbiVie slipped 11 cents to $54.02 while Shire stock collapsed $79.46 to $165.11.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.